Upender Velaparthi

1.0k total citations
20 papers, 362 citations indexed

About

Upender Velaparthi is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Upender Velaparthi has authored 20 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Upender Velaparthi's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Upender Velaparthi is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Upender Velaparthi collaborates with scholars based in United States, India and Germany. Upender Velaparthi's co-authors include Marcia I. Dawson, Peter D. Hobbs, Mark D. Wittman, Daniel J. Pollart, David W. Thomas, J. S. Yadav, Marco M. Gottardis, Joan M. Carboni, Ann Greer and Dolatrai M. Vyas and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and The Journal of Organic Chemistry.

In The Last Decade

Upender Velaparthi

18 papers receiving 349 citations

Peers

Countries citing papers authored by Upender Velaparthi

Since Specialization

Citations

This map shows the geographic impact of Upender Velaparthi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upender Velaparthi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upender Velaparthi more than expected).

Fields of papers citing papers by Upender Velaparthi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Upender Velaparthi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upender Velaparthi. The network helps show where Upender Velaparthi may publish in the future.

Co-authorship network of co-authors of Upender Velaparthi

This figure shows the co-authorship network connecting the top 25 collaborators of Upender Velaparthi. A scholar is included among the top collaborators of Upender Velaparthi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Upender Velaparthi. Upender Velaparthi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diversity-Oriented C–H Activation Reactions of the Naphthalene Scaffold 2025 ·Journal of the American Chemical Society ·Zhoulong Fan, Md Emdadul Hoque, Kevin Wu, Maximilian D. Palkowitz, Upender Velaparthi, Kevin W. Gillman, Jennifer X. Qiao, Jin‐Quan Yu	0
2	The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Upender Velaparthi, Mark G. Saulnier, David B. Frennesson, Peiying Liu, Audris Huang, John S. Tokarski, Aberra Fura, Thomas Spires, John A. Newitt, (unknown), Mary T. Obermeier, Paul A. Elzinga, Marco M. Gottardis, Lata Jayaraman, Gregory D. Vite, Aaron Balog	7
3	Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one 2010 ·Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi, Mark G. Saulnier, Mark D. Wittman, Peiying Liu, David B. Frennesson, Kurt Zimmermann, Joan M. Carboni, Marco M. Gottardis, Aixin Li, Ann Greer, Wendy Clarke, Zheng Yang, Krista Menard, Francis Y. Lee, George L. Trainor, Dolatrai M. Vyas	16
4	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier, David B. Frennesson, Mark D. Wittman, Kurt Zimmermann, Upender Velaparthi, David R. Langley, (unknown), (unknown), Joan M. Carboni, Aixin Li, Ann Greer, Zheng Yang, Praveen Balimane, Marco M. Gottardis, Ricardo M. Attar, Dolatrai M. Vyas	20
5	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann, Mark D. Wittman, Mark G. Saulnier, Upender Velaparthi, David R. Langley, (unknown), David B. Frennesson, Joan M. Carboni, Aixin Li, Ann Greer, Marco M. Gottardis, Ricardo M. Attar, Zheng Yang, Praveen Balimane, Lorell Discenza, Dolatrai M. Vyas	17
6	Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R) 2007 ·Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi, Mark D. Wittman, Peiying Liu, (unknown), Kurt Zimmermann, (unknown), Joan M. Carboni, Aixin Li, Ricardo M. Attar, Marco M. Gottardis, Ann Greer, ChiehYing Y. Chang, (unknown), John S. Sack, (unknown), David R. Langley, Balu Balasubramanian, Dolatrai M. Vyas	35
7	Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile 2007 ·Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi, Peiying Liu, Balu Balasubramanian, Joan M. Carboni, Ricardo M. Attar, Marco M. Gottardis, Aixin Li, Ann Greer, Mary Zoeckler, Mark D. Wittman, Dolatrai M. Vyas	34
8	Discovery and Initial SAR of 3‐(1H‐Benzo[d]imidazol‐2‐yl)pyridin‐2(1H)‐ones as Inhibitors of Insulin‐Like Growth Factor 1‐Receptor (IGF‐1R). 2007 ·ChemInform ·Upender Velaparthi, (unknown)	1
9	Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman, Balu Balasubramanian, (unknown), Upender Velaparthi, (unknown), (unknown), Joan M. Carboni, Aixin Li, Ann Greer, Ricardo M. Attar, Marco M. Gottardis, ChiehYing Y. Chang, Bruce L. Jacobson, (unknown), Steven Hansel, Mary Zoeckler, Dolatrai M. Vyas	19
10	Microwave-assisted synthesis of primary amine HX salts from halides and 7 M ammonia in methanol 2003 ·Tetrahedron Letters ·Mark G. Saulnier, Kurt Zimmermann, (unknown), (unknown), Upender Velaparthi, Mark D. Wittman, David B. Frennesson	22
11	Michellamine Alkaloids Inhibit Protein Kinase C 1999 ·Archives of Biochemistry and Biophysics ·E. Lucile White, Wan‐Ru Chao, Larry J. Ross, David W. Borhani, Peter D. Hobbs, Upender Velaparthi, Marcia I. Dawson	17
12	Antioxidant activity of michellamine alkaloids. 1999 ·PubMed ·E. Lucile White, L. J. N. Ross, Peter D. Hobbs, Upender Velaparthi, Marcia I. Dawson	9
13	Stereospecific Syntheses of Michellamines A and C 1997 ·Synlett ·Peter D. Hobbs, Upender Velaparthi, Marcia I. Dawson	47
14	The first stereospecific synthesis of michellamine B 1996 ·Chemical Communications ·Peter D. Hobbs, Upender Velaparthi, (unknown), Daniel J. Pollart, David W. Thomas, Marcia I. Dawson	48
15	The synthesis and biological activity of two analogs of the anti‐HIV alkaloid michellamine B 1996 ·Journal of Heterocyclic Chemistry ·Upender Velaparthi, Daniel J. Pollart, (unknown), Peter D. Hobbs, Cris Olsen, Wan‐Ru Chao, (unknown), (unknown), David W. Thomas, Anjali Pandey, John A. Lawson, Marcia I. Dawson	25
16	A practical preparation of functionalized alkylbenzoquinones: synthesis of maesanin and irisquinone 1992 ·The Journal of Organic Chemistry ·J. S. Yadav, Upender Velaparthi, A. V. R. RAO	11
17	ChemInform Abstract: A Practical Preparation of Functionalized Alkylbenzoquinones: Synthesis of Maesanin and Irisquinone. 1992 ·ChemInform ·J. S. Yadav, Upender Velaparthi, A. V. R. RAO	1
18	Total syntheses of (±) cervinomycins A1 and A2 1991 ·Tetrahedron Letters ·AV Rama Rao, J. S. Yadav, K. Kishta Reddy, Upender Velaparthi	24
19	Stereoconvergent synthesis of a potent mosquito larvicide : (2E,4E,8E,10Z)-N-(2-methyl propyl)-2,4,8,10-dodecatetraeneamide 1990 ·Tetrahedron ·G. V. M. Sharma, (unknown), Upender Velaparthi	9
20	ChemInform Abstract: Stereoconvergent Synthesis of a Potent Mosquito Larvicide: (2E,4E,8E,10Z)‐N‐(2‐Methyl‐propyl)‐2,4,8,10‐dodecatetraeneamide. 1990 ·ChemInform ·Gangavaram V. M. Sharma, (unknown), Upender Velaparthi	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact